Effect of Physical Exercise on Platelet Activity and the von-Willebrand-Factor in Patients with Persistent Lone Atrial Fibrillation

Journal of Interventional Cardiac Electrophysiology

Volumn 10, Issue 2, 2004, Pages 139-146

  Goette, Andreas ^a   Weber, Mathias ^a   Lendeckel, Uwe ^a   Welte, Tobias ^a   Lutze, Gerd ^a   Klein, Helmut U ^a  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

Author keywords

Atrial fibrillation; Exercise; Platelets; Stroke; Thrombin; Von Willebrand factor

Indexed keywords

BETA THROMBOGLOBULIN; COUMARIN; DIGOXIN; FIBRINOGEN; NORADRENALIN; PROTHROMBIN; THROMBOCYTE FACTOR 4; VERAPAMIL; VON WILLEBRAND FACTOR;

ADULT; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; EXERCISE; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HEMODYNAMIC PARAMETERS; HUMAN; LUNG GAS EXCHANGE; MALE; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; SINUS RHYTHM; THROMBIN TIME; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; THROMBOEMBOLISM; WORKLOAD;

AGED; ANALYSIS OF VARIANCE; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; EXERCISE; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET ACTIVATION; PROBABILITY; PULMONARY GAS EXCHANGE; REFERENCE VALUES; RISK ASSESSMENT; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; VON WILLEBRAND FACTOR;

EID: 1942487202     PISSN: 1383875X     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:JICE.0000019267.24208.c4     Document Type: Article

References (34)

1. Brand FN, Abbott RD, Kannel WB, Wolf PA. Characteristics and prognosis of lone atrial fibrillation: 30 years follow-up in the Framingham Study. JAMA 1985;254:3449-3453.
2. EAFT Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischemic attack or minor stroke. Lancet 1993;342:1255-1262.
3. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenburg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD, Atrial Fibrillation Follow-Up Investigation of Rhytm Management Investigation. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-1833.
4. Lip GY, Lip PL, Zarifis J, Watson RD, Bareford D, Lowe GD, Beevers DG. Fibrin D-dimer and β-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low dose warfarin and aspirin. Circulation 1996;94:425-431.
5. Kumagai K, Fukunami M, Ohmori M, Kitabatake A, Kamada T, Hoki N. Increased intracardiovascular clotting in patients with chronic atrial fibrillation. J Am Coll Cardiol 1990;16:377-380.
6. Sohara H, Amitani S, Kurose M, Miyahara K. Atrial fibrillation activates platelets and coagulation in a time-dependent manner: A study in patients with paroxysmal atrial fibrillation. J Am Coll Cardiol 1997;29:106-112.
7. Ikeda U, Yamamoto K, Shimada K. Biochemical markers of coagulation activation in mitral stenosis, atrial fibrillation and cardiomyopathy. Clin Cardiol 1997;20:7-10.
8. Conway DS, Pearce LA, Chin BS, Hart RG, Lip GY. Plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 1321 patients with non-valvular atrial fibrillation: Relationship to stroke risk factors. Circulation 2002;106:1962-1967.
9. Shinohara H, Fukuda N, Soeki T, Takeichi N, Yui Y, Tamura Y, Oki T. Relationship between flow dynamics in the left atrium and hemostatic abnormalities in patients with non-valvular atrial fibrillation. Jpn Heart J 1998;39:721-730.
10. Minamino T, Kitakaze M, Asanuma H, Ueda Y, Koretsune Y, Kuzuya T, Hori M. Plasma adenosine levels and platelet activation in patients with atrial fibrillation. Am J Cardiol 1999;83:194-198.
11. Minamino T, Kitakaze M, Sanada S, Asanuama H, Kurotobi T, Koretsune Y, Fukunami M, Kuzuya T, Hoki N, Hori M. Increased expression of P-selectin on platelets is a risk factor for silent cerebral infarction in patients with atrial fibrillation. Role of nitric oxide. Circulation 1998;98:1721-1727.
12. Goette A, Ittenson A, Hoffmanns P, Reek S, Hartung W, Klein H, Ansorge S, Geller JC. Increased expression of P-selectin in patients with chronic atrial fibrillation. Pacing Clin Electrophysiol 2000;23:1872-1875.
13. Hambrecht R, Hilbrich L, Erbs S, Gielen S, Fiehn E, Schoene N, Schuler G. Correction of endothelial dysfunction in chronic heart failure: Additional effects of exercise training and oral L-arginine supplementation. J Am Coll Cardiol 2000;35:706-713.
14. Hambrecht R, Wolf A, Gielen S, Linke A, Hofer J, Erbs S, Schoene N, Schuler G. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med 2000;342:454-460.
15. El-Sayed MS, Sale C, Jones PG, Chester M. Blood hemostasis in exercise and training. Med Sci Sports Exerc 2000;32:918-925.
16. Koenig W, Ernst E. Exercise and thrombosis. Coron Artery Dis 2000;11:123-127.
17. Clauss A. Eine gerinnungs-physiologische schnellmethode zur bestimmung des fibrinogens. Act Haematol 1957;17:237-246.
18. Cerletti C, Evangelista V, Molino M, de Gaetano G. Platelet activation by polymorphonuclear leukocytes: Role of cathepsin G and P-selectin. Thromb Haemost 1995;74:218-223.
19. Murohara T, Parkinson SJ, Waldman SA, Lefer AM. Inhibition of nitric oxide biosynthesis promotes P-selectin expression in platelets: Role of protein kinase C. Arterioscler Thromb Vasc Biol 1995;15:2068-2075.
20. Herbert JM, Tissinier A, Defreyn G, Maffrand JP. Inhibitory effect of clopidogrel on platelet adhesion and intimal proliferation after arterial injury in rabbits. Arterioscler Thromb 1993;13:1171-1179.
21. Asakura H, Hifumi S, Jokaji H, Saito M, Kumabashiri I, Uotani C, Morishita E, Yamazaki M, Shibata K, Mizuhashi K, Mifune J, Matsuda E. Prothrombin fragment F1 + 2 and thrombin-antithrombin III complex are useful markers of the hypercoagulable state in atrial fibrillation. Blood Coagul Fibrinolysis 1992;3:469-473.
22. Iga K, Izumi C, Inokok M, Kitaguchi S, Himura Y, Gen H, Konishi T. Increased thrombin-antithrombin III complex during an episode of paroxysmal atrial fibrillation. Int J Cardiol 1998;66:153-156.
23. Pongratz G, Brandt-Pohlmann M, Henneke KH, Pohle C, Zink D, Gehling G, Bachmann K. Platelet activation in embolic and preembolic status of patients with nonrheumatic atrial fibrillation. Chest 1997;111:929-933.
24. Turitto VT, Hall CL. Mechanical factors affecting hemostasis and thrombosis. Thromb Res 1998;92:S25-S31.
25. Cai H, Li Z, Goette A, Mera F, Honeycutt C, Feterik K, Wilcox JN, Dudley SC Jr, Harrison DG, Langberg JJ. Downregulation of nitric oxide synthase expression and nitric oxide production in atrial fibrillation: Potential mechanisms for atrial thrombosis and stroke. Circulation 2002;106:2854-2858.
26. Minamino T, Kitakaze M, Sato H, Asanuma H, Funaya H, Koretsune Y, Hori M. Plasma levels of nitrite/nitrate and platelet cGMP levels are decreased in patients with atrial fibrillation. Arterioscler Thromb Vasc Biol 1997;17:3191-3195.
27. Goette A, Staack T, Rocken C, Arndt M, Geller JC, Huth C, Ansorge S, Klein HU, Lendeckel U. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme and in human atria during atrial fibrillation. J Am Coll Cardiol 2000;35:1669-1677.
28. Sperry JL, Deming CB, Bian C, Walinsky PL, Kass DA, Kolodgie FD, Virmani R, Kim AY, Rade JJ. Wall tension is a potent negative regulator of in vivo thrombomodulin expression. Circ Res 2003;92:41-47.
29. Mondillo S, Sabatini L, Agricola E, Ammaturo T, Guerrini F, Barbati R, Pastore M, Fineschi D, Nami R. Correlation with left atrial size, prothrombotic state and markers of endothelial dysfunction in patients with lone chronic non-rheumatic atrial fibrillation. Int J Cardiol 2000;75:227-232.
30. Fukuchi M, Watanabe J, Kumagai K, Katori Y, Baba S, Fukuda K, Yagi T, Iguchi A, Yok. Increased von Willebrand Farcotr in the endocardium as a local predisposing factor for thrombogenesis in overloaded human atrial appendage. J Am Coll Cardiol 2001;37:1436-1442.
31. Li-Saw-Hee FL, Blann AD, Edmunds E, Gibbs CR, Lip GY. Effect of acute exercise on the raised plasma fibrinogen, soluble P-selectin and von Willebrand factor levels in chronic atrial fibrillation. Clin Cardiol 2001;24:409-414.
32. Kamath S, Chin BS, Blann AD, Lip GY. A study of platelet activation in paroxysmal, persistent and permanent atrial fibrillation. Blood Coagul Fibrinolysis 2002;13:627-636.
33. Kamath S, Blann AD, Chin BS, Lanza F, Aleil B, Cazenave JP, Lip GY. A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy. Eur Heart J 2002;23:1788-1795.
34. Kamath S, Blann AD, Chin BS, Lip GY. A prospective randomised trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation. J Am Coll Cardiol 2002;40:484-490.